Colombia’s highest administrative court suspended Decree 0182 on May 4, 2026, freezing a territorial restructuring of health insurers that would have forcibly reassigned an estimated 6.6 million affiliates.

POLICY & MARKETS · SEPTEMBER 12, 2026 · LATIN AMERICA
Two consecutive regulatory decrees. Two suspensions by the same court. The Consejo de Estado, Colombia’s highest administrative tribunal, issued a provisional suspension of Decreto 0182 de 2026 on May 4, 2026, halting the Petro government’s attempt to restructure the territorial operation of the country’s health-insurance market by executive decree — a move that had already begun displacing affiliates before the court intervened.
The decree, issued by the Ministerio de Salud y Protección Social, Colombia’s health ministry, on February 25, 2026, established minimum market-share thresholds that Entidades Promotoras de Salud (EPS), the country’s managed-care insurers, would need to meet in order to remain authorized in each department and municipality. In departments with more than two million inhabitants, the floor was set at 5% of affiliates; in mid-sized departments of between 390,001 and two million people, 10%; in smaller departments of between 100,000 and 390,000 inhabitants, 15%, according to the decree text reported by Infobae. At the municipal level, cities with more than 500,000 inhabitants could only retain EPS with more than 3% of local affiliates, per the same reporting.
The practical consequence was concentration. According to a Ministry of Health document of more than 450 pages reviewed by Infobae, Nueva EPS — a state-linked insurer under government intervention since April 3, 2024, per the Superintendencia Nacional de Salud, Colombia’s health-insurance regulator — was the only entity authorized to operate in more than 400 of the country’s 1,102 municipalities. In those territories, free choice of insurer was effectively eliminated.
A court ruling, a prior precedent, and a pattern
The suspension came after a nulity action filed by Katherine Miranda Peña, a congresswoman for the Alianza Verde party, who invoked the medio de control de nulidad under Article 137 of the Código de Procedimiento Administrativo y de lo Contencioso Administrativo (CPACA). The Sección Primera of the Consejo de Estado determined that the decree failed the principle of proportionality and did not respect the constitutional right to free choice of insurer, according to Infobae’s reporting on the May 4 ruling.
The suspension was not the first. The Tribunal Administrativo de Antioquia, a regional administrative court, had already issued a precautionary measure on March 10, 2026, suspending the decree’s implementation. Magistrate Daniel Montero Betancur, writing for the Sala Tercera, ordered authorities to ‘abstain from materializing the provisions contained in Decreto 0182,’ pending a final ruling on the merits, according to the tribunal’s published decision. That earlier suspension followed a popular action filed by citizen Víctor Raúl Palacio Bohórquez, who alleged methodological irregularities, risks to free competition, and deficiencies in Nueva EPS’s operational capacity.
Acemi, the Asociación Colombiana de Empresas de Medicina Integral, Colombia’s managed-care industry association, had warned from the outset that the decree replicated the purpose of Decreto 0885 de 2025 — itself suspended by the Consejo de Estado in October 2025 — and therefore constituted, in Acemi’s characterization, ‘a contempt of the judicial ruling and for that reason illegal,’ according to the association’s published communiqué. The government, through Health Minister Guillermo Alfonso Jaramillo, rejected that framing, stating that the decree corrected structural failures in the insurance model rather than arbitrarily transferring users, per the ministry’s official communications.
Nueva EPS at the centre of a contested consolidation
The operational logic of the decree pointed toward Nueva EPS as the dominant beneficiary. An analysis published by El Tiempo, cited by Infobae, projected that Nueva EPS would receive 2,618,804 additional affiliates, bringing its total to 14,199,071 — a 22.6% increase from its January base of 11,580,267. The overall redistribution was projected to affect approximately 6.5 million affiliates across the system, according to the same analysis. A separate Infobae report cited a figure of 6.6 million people already impacted by the time the Consejo de Estado acted on May 4.
The Asociación Colombiana de Hospitales y Clínicas (Achc), Colombia’s hospital and clinic industry body, raised a direct objection to that consolidation. In a letter dated March 2, 2026, addressed to Minister Jaramillo, the Achc stated that Nueva EPS carries a debt of approximately COP 6.7 trillion with the provider network and exhibits high levels of payment delinquency, according to Infobae’s reporting on the letter. The Achc’s position was unambiguous: ‘Nueva EPS cannot receive more users.’ The complaint filed before the Tribunal Administrativo de Antioquia added that Nueva EPS had recorded a 107% year-over-year increase in user complaints, according to Infobae.
Most of the figures cited above trace to Infobae’s reporting and to El Tiempo’s analysis, both of which are press sources rather than primary regulatory filings. The Ministry of Health’s own 450-page territorial authorization document, as described by Infobae, is the closest available primary reference for the municipal-level authorization map; the underlying data has not been independently corroborated by a separate primary issuer in the available record.
The decree’s 60-day transition window meant that involuntary transfers had already begun executing before the Consejo de Estado’s May 4 suspension. Affiliates reassigned during that window were required to remain with their new EPS for at least 60 days before exercising the right to switch, per the decree’s own terms as reported by Infobae. The court’s intervention does not automatically reverse transfers already completed — the available record does not clarify the remedial mechanism for affiliates reassigned prior to the suspension.
What to Watch
- The Consejo de Estado’s final ruling on the merits of Miranda Peña’s nulity action — a definitive annulment would foreclose the regulatory pathway entirely and force a legislative approach.
- Whether the government introduces a new decree or pursues congressional legislation to achieve territorial EPS consolidation, given that two consecutive decrees have now been suspended by the same court.
- The Superintendencia Nacional de Salud’s administrative acts implementing the territorial map — the Ministry’s 450-page document noted that practical application depended on acts not yet issued by the regulator at the time of reporting.
The deeper structural problem the decree was designed to solve — eight EPS under government intervention, collectively managing more than 24 million affiliates, with documented financial fragility, according to Acemi — remains unresolved. A court suspension preserves the status quo; it does not repair it. If the government cannot achieve territorial consolidation by regulation, the same insurer-fragmentation dynamics that motivated the decree will continue to generate access failures in low-density municipalities, with no named legislative vehicle yet on the table to address them.
Decreto 0182: Regulatory Suspension Timeline
- Projected affiliate redistribution: 6.5–6.6 million beneficiaries
- Nueva EPS projected to receive 2,618,804 new affiliates (22.6% growth from January base of 11,580,267)
- Minimum market-share thresholds: 3–15% depending on department population and municipality size
- Mandatory 60-day stay period for involuntary transfers (suspended pending resolution)
Related coverage
THE HEALTHSIGNALS BRIEF
A fortnightly PDF compiling our analysis on pharma, medical devices, health policy and epidemiology across Latin America and the United States.
Built for pharma, market-access, regulatory, policy and investor teams, with the main findings of our gated reports included.







